Apex One put it better than me (bold mine) :
Quote:From Natera point of view a 20 plus billion dollar company would never PR an official partnership with a clinical stage biotech especially with the reputation CytoDyn has had in the past. Unless there was significant upside potential for Natera to market the success of the phase2 LERONLIMAB trial as a further advancement in the cancer research field
I know there are other events coming up for the company to meet with potential partners but there are vehicles for meetings other than at conferences, such as F2F, Zoom, Western Union, phone calls, pony express, telegraph and other assorted technologies. IOW, no reason to wait if the data sets are continuing to be, quoting Dr. JL, remarkable. As a former sales rep I do recall a sales manager grinding on us for not getting more sits by saying: What are you waiting for, per-minute-bill-rates to drop? Pick up the phone and start dialing!